Sharon Bio-Medicine Ltd

Sharon Bio-Med. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sharon Bio-Medicine Ltd

₹ 3.30 -4.35%
28 Mar 2019
sharonbio.com BSE: 532908 NSE: SHARONBIO
About

Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.

[ add key points ]
Website BSE NSE - BZ
  • Market Cap ₹ 39.2 Cr.
  • Current Price ₹ 3.30
  • High / Low ₹ /
  • Stock P/E 2.06
  • Book Value ₹ -49.6
  • Dividend Yield 0.00 %
  • ROCE 8.36 %
  • ROE %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company's working capital requirements have reduced from 48.8 days to 30.8 days

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
45.79 35.80 43.25 45.24 48.57 48.89 45.37 44.36 49.77 37.84 55.16 57.75 44.23
37.71 31.81 38.60 38.72 42.11 42.27 38.52 38.01 43.40 36.99 44.46 47.46 40.72
Operating Profit 8.08 3.99 4.65 6.52 6.46 6.62 6.85 6.35 6.37 0.85 10.70 10.29 3.51
OPM % 17.65% 11.15% 10.75% 14.41% 13.30% 13.54% 15.10% 14.31% 12.80% 2.25% 19.40% 17.82% 7.94%
0.49 0.38 0.64 1.01 2.08 0.66 0.47 0.56 1.13 0.72 0.85 2.09 0.79
Interest 0.04 0.04 0.04 0.05 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.01 0.01
Depreciation 2.50 2.83 2.88 2.91 2.89 2.76 2.82 2.85 2.80 2.66 2.69 2.91 2.49
Profit before tax 6.03 1.50 2.37 4.57 5.61 4.49 4.47 4.03 4.68 -1.11 8.84 9.46 1.80
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
6.03 1.50 2.37 4.56 5.61 4.49 4.48 4.02 4.68 -1.11 8.85 9.47 1.81
EPS in Rs 0.51 0.13 0.20 0.38 0.47 0.38 0.38 0.34 0.39 -0.09 0.74 0.80 0.15
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Jun 2009 Jun 2010 Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 9m Mar 2020 Mar 2021 Mar 2022 Mar 2023
420 496 606 785 1,060 1,314 834 253 171 173 188 195
381 445 535 690 939 1,157 868 387 145 151 162 170
Operating Profit 39 52 71 95 120 157 -34 -134 26 22 26 25
OPM % 9% 10% 12% 12% 11% 12% -4% -53% 15% 13% 14% 13%
2 -0 1 1 1 2 -74 -69 -72 4 3 4
Interest 14 21 27 34 43 59 94 71 0 0 0 0
Depreciation 4 6 8 9 12 15 19 15 11 12 11 11
Profit before tax 22 24 36 53 66 85 -221 -289 -56 14 18 19
Tax % 16% 22% 15% 22% 20% 18% 2% 3% 0% 0% 0% 0%
19 19 31 42 53 70 -226 -299 -56 14 18 19
EPS in Rs 1.76 1.77 2.95 3.94 5.01 6.59 -18.99 -25.16 -4.75 1.18 1.49 1.60
Dividend Payout % 7% 8% 6% 5% 3% 5% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -13%
5 Years: %
3 Years: 4%
TTM: 4%
Compounded Profit Growth
10 Years: -8%
5 Years: %
3 Years: 4%
TTM: 8%
Stock Price CAGR
10 Years: -22%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Jun 2009 Jun 2010 Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital 11 11 11 11 11 21 24 24 24 1 1 1
Reserves 96 112 188 182 233 323 94 -205 -664 -627 -610 -592
262 343 344 508 644 725 824 836 828 828 828 828
29 35 44 74 84 92 69 68 88 88 80 76
Total Liabilities 397 501 586 774 972 1,162 1,012 723 276 290 299 313
56 184 181 201 272 325 332 319 149 141 135 128
CWIP 107 23 27 60 43 15 0 0 0 0 0 0
Investments 1 4 4 4 4 1 1 0 0 0 0 0
233 290 374 509 654 820 678 404 128 149 164 185
Total Assets 397 501 586 774 972 1,162 1,012 723 276 290 299 313

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Jun 2009 Jun 2010 Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-50 -28 -36 -53 -70 -69 -82 -28 35 4 23 41
-66 -51 -8 -61 -64 -27 -10 0 -7 -4 -3 -3
47 78 46 117 134 103 96 22 0 0 0 0
Net Cash Flow -69 -1 1 2 -0 6 4 -6 28 0 20 38

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Jun 2009 Jun 2010 Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 116 117 116 121 122 115 138 264 47 62 52 49
Inventory Days 90 102 112 109 105 106 136 198 173 209 162 149
Days Payable 23 23 23 28 24 20 23 44 214 183 167 155
Cash Conversion Cycle 183 195 205 202 203 201 251 418 7 88 48 43
Working Capital Days 176 188 200 203 197 200 261 490 9 56 60 31
ROCE % 11% 11% 13% 14% 14% 15% -5% -17% 7% 8% 8%

Shareholding Pattern

Numbers in percentages

Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023
32.53% 32.53% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.01% 0.01% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
67.46% 67.46% 99.97% 99.97% 99.98% 99.97% 99.97% 99.97% 99.97% 99.99% 99.99% 99.98%
No. of Shareholders 24,83624,83024,85424,85424,85424,85424,85424,85424,85324,83724,83724,837

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings